Breaking News
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
December 13, 2018 - Food poisoning discovery could save lives
December 13, 2018 - Cloned antibodies show potential to treat, diagnose life-threatening fungal infections
December 13, 2018 - Exercise may reduce colorectal cancer risk after weight loss
December 13, 2018 - Russian scientists create hardware-information system for brain disorders treatment
December 13, 2018 - Moderate alcohol consumption linked with lower risk of hospitalization
December 13, 2018 - Nurturing Healthy Neighborhoods | NIH News in Health
December 13, 2018 - Rise in meth and opioid use during pregnancy
December 13, 2018 - Researchers gain new insights into pediatric tumors
December 13, 2018 - FSU study finds racial disparity among adolescents receiving flu vaccine
December 13, 2018 - Drug cocktail induces cancer cell death by switching off energy supply
December 13, 2018 - Baculovirus virion completely eliminates liver-stage parasites in mouse model
December 13, 2018 - Researchers create noninvasive technology that detects when nerve cells fire
December 13, 2018 - Treating patients with hypertension induced albuminuria
December 13, 2018 - New substance could improve efficacy of established breast cancer treatments
December 13, 2018 - Scientists develop new stem cell line to study conversion of stem cells into muscle
December 13, 2018 - Re-programming the body’s energy pathway boosts kidney self-repair
December 13, 2018 - Research findings could help improve treatment of anxiety and post-traumatic stress disorders
December 13, 2018 - The Microbiome Movement announce Microbiotica as official industry partner
December 13, 2018 - New study reveals potential benefits of cEEG monitoring for infant ICU patients
December 13, 2018 - Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer
December 13, 2018 - International investigators fight against the negative campaign on benzodiazepines
December 13, 2018 - Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders
December 13, 2018 - FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections
December 13, 2018 - Are scientists studying the wrong kind of mice?
December 13, 2018 - Computer memory: A scientific team builds a virtual model of a key brain region
December 13, 2018 - Visual inspection alone is insufficient to diagnose skin cancer
December 13, 2018 - Paternal grandfather’s access to food associated with grandson’s mortality risk
December 13, 2018 - Our brain senses angry voices in a flash, study shows
December 13, 2018 - PM2.5 Exposure Linked to Asthma Rescue Medication Use
December 13, 2018 - Can’t exercise? A hot bath may help improve inflammation, metabolism, study suggests
December 13, 2018 - Can artificial intelligence help doctors with the human side of medicine?
December 13, 2018 - Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain
December 13, 2018 - NIH offers support for HIV care and prevention research in the southern United States
December 12, 2018 - Activating brain region could revive the urge to socialize among opioid addicts
December 12, 2018 - Relationship impairment appears to interfere with seeking mental health treatment in men
December 12, 2018 - Sleep, Don’t Cram, Before Finals for Better Grades
December 12, 2018 - Effective treatments for urticarial vasculitis
December 12, 2018 - Gun violence is a public health issue: One physician’s story
December 12, 2018 - The Science of Healthy Aging
December 12, 2018 - Yes to yoghurt and cheese: New improved Mediterranean diet
December 12, 2018 - Researchers uncover a number of previously unknown insecticide resistance mechanisms
December 12, 2018 - Regulating the immune system’s ‘regulator’
December 12, 2018 - In breaking bad news, the comfort of silence
December 12, 2018 - Study finds upward link between alcohol consumption and physical activity in college students
December 12, 2018 - FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall
December 12, 2018 - Weight history at ages 20 and 40 could help predict patients’ future risk of heart failure
December 12, 2018 - Presence of antiphospholipid antibodies tied to first-time MI
December 12, 2018 - DNA analysis finds that stethoscopes are teaming with bacteria
December 12, 2018 - New study could help inform research on preventing falls
December 12, 2018 - Women and men with heart attack symptoms receive different care from EMS
December 12, 2018 - Disrupted biological clock can contribute to onset of diseases, USC study shows
December 12, 2018 - New publications generate controversy over the value of reducing salt consumption in populations
December 12, 2018 - New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity
December 12, 2018 - Specific class of biomarkers can accurately indicate the severity of cancer
December 12, 2018 - Meds Taken Do Not Vary With ADL Impairment in Heart Failure
December 12, 2018 - Long-term study shows that HIV-2 is deadlier than previously thought
December 12, 2018 - People living near oil and gas wells show early signs of cardiovascular disease
December 12, 2018 - IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony
December 12, 2018 - People who eat red meat have high levels of chemical associated with heart disease, study finds
December 12, 2018 - New method uses water molecules to unlock neurons’ secrets
December 12, 2018 - Genetics study offers hope for new acne treatment
December 12, 2018 - New computer model predicts prostate cancer progression
December 12, 2018 - Nobel Laureates lecture about immune checkpoint therapy for cancer treatment
December 12, 2018 - More Illnesses From Tainted Romaine Lettuce Reported
December 12, 2018 - Aspirin could reduce HIV infections in women
December 12, 2018 - The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors
December 12, 2018 - Insights into magnetotactic bacteria could guide development of biological nanorobots
December 12, 2018 - Sacrificial immune cells alert body to infection
December 12, 2018 - Low-salt diet may be more beneficial for females than males
December 12, 2018 - Major soil organic matter compound battles chronic wasting disease
December 12, 2018 - Findings may open up new ways to treat dwarfism and other ER-stress-related conditions
December 12, 2018 - New computational model provides clearer picture of shape-changing cells’ structure and mechanics
December 12, 2018 - 10 Facts on Patient Safety
December 12, 2018 - Poorest dying nearly 10 years younger than the rich in ‘deeply worrying’ trend for UK
December 12, 2018 - Innovative care model for children with ASD reduces use of behavioral drugs in ED
December 12, 2018 - Spending time in and around Hong Kong’s waters linked to better health and wellbeing
December 12, 2018 - Simple measures to prevent weight gain over Christmas
December 12, 2018 - Research advances offer hope for patient-tailored AML treatment
December 12, 2018 - Researchers discover a ‘blind spot’ in atomic force microscopy
Wearable defibrillator reduces overall mortality, but not sudden cardiac death

Wearable defibrillator reduces overall mortality, but not sudden cardiac death

image_pdfDownload PDFimage_print

Wearing a lightweight vest equipped with a cardioverter defibrillator that detects abnormal heart rhythms in addition to taking recommended medications is associated with a reduction in the likelihood of dying during the first 90 days following a heart attack in people whose heart function was also impaired, according to a study presented at the American College of Cardiology’s 67th Annual Scientific Session. People who wore the wearable cardioverter defibrillator (WCD) during the study timeframe were 35 percent less likely to die for any reason compared with those who received medications alone.

While the study did not find a significant benefit in terms of reducing sudden cardiac death, the primary endpoint, the study did find that the wearable defibrillator was associated with fewer overall deaths.  

“It is possible that sudden deaths were misclassified as it’s difficult to define sudden death with accuracy when a death is unwitnessed and there is little documentation,” said Jeffrey E. Olgin, MD, professor and chief of cardiology, University of California San Francisco and lead author of the study. “But the cause of death is irrelevant if we can prevent it. This study found that the device was associated with fewer deaths among people recovering from a heart attack with low ejection fraction. It’s also the first therapy associated with a mortality benefit above and beyond standard medical therapy immediately after heart attack.”

The Vest Prevention of Early Sudden Death Trial (VEST) is the first randomized, controlled, multi-center trial of the wearable cardioverter defibrillator. It was designed to test whether this device could effectively reduce sudden death in patients who had recently suffered a heart attack and had reduced heart function (defined as a low ejection fraction of 35 percent or less) where the heart wasn’t able to pump sufficient blood to the rest of the body, which is indicative of a sizable heart attack.

Generally, the three-month mortality rate for people recovering from a heart attack who also have reduced heart function is around 5 percent, Olgin said, and that is with optimal medical management. Similarly, in VEST, 4.9 percent of participants in the control group died compared with only 3.2 percent of those wearing the WCD—an absolute difference of 1.7 percent.  

“There is a very high risk of death immediately after a heart attack that tails off after about three months,” Olgin said. “The challenge is that we don’t currently have a good way of preventing deaths during this very vulnerable period.”

Despite the high rate of sudden death in the months following a heart attack, implantable cardioverter defibrillators (ICDs) placed in the chest aren’t currently indicated for this patient population before 40-90 days for several reasons. First, large studies have failed to show that implanting an ICD during this period results in long-term reductions in mortality. Second, in many cases someone’s ejection fraction will improve in the ensuing months post-heart attack. In VEST, for example, 60 percent of people with low ejection fraction in the first three months after heart attack recovered and no longer met the criteria for an ICD at 90 days. Lastly, there is competing risk of death from other causes not preventable with a defibrillator—for example, another heart attack or cardiac rupture.

According to Olgin, these new findings suggest WCDs could fill the gap in cardiac therapy until patients can be evaluated for an ICD. Current guidelines recommend the WCD as a potential tool that practitioners can use, but the researchers believe findings from this large randomized trial will add important data to further inform these guideline recommendations.

The LifeVest WCD is worn under clothing, directly against the skin and works by continuously monitoring a patient’s heart and sounding alarms and/or giving verbal commands to encourage people to seek medical care, if needed. If a life-threatening heart rhythm is detected, the device delivers a shock to restore a normal heart rhythm.

“What’s nice about the wearable defibrillator is that it’s non-invasive and it’s not permanent,” Olgin said. “Based on our results, I think we’ll see more widespread use of this device in these patients.”

The trial enrolled 2,300 adult patients admitted to the hospital for heart attack with an ejection fraction of ≤ 35 percent across more than 100 trial sites in four countries. Upon discharge, patients were randomized 2 to 1 to either receive the WCD plus guideline-directed medical therapy or guideline-directed medical therapy alone for 90 days to determine the potential mortality benefit of the WCD.

Patients were advised and reminded to wear the WCD as much as possible and only take it off for bathing; participants who wore the WCD did so for an average of 21 hours a day. The primary outcome was sudden death at three months and secondary outcomes were total and cause-specific mortality, non-fatal ventricular arrhythmias and hospitalizations. Participants and sites were not blinded to the treatment arm, but they were blinded to any arrhythmia detections during the follow-up. Un-blinding could be requested if a participant had a shock, cardiac arrest or syncopal event. Outcomes were adjudicated by an independent, blinded panel.

The vast majority of patients in both groups—upwards of 85 percent—received appropriate guideline-directed treatment for post-heart attack management, as well as heart failure management given patients’ reduced ejection fraction. At the end of the study, researchers searched the National Death Index for participants lost to follow up. The rate of cardiovascular-related re-hospitalizations was 25 percent and was similar in both groups.

The study was originally designed with a primary outcome of total mortality. However, because of enrollment difficulties early in the study, the estimated sample size of 4,500 participants became infeasible. After the first 213 participants were enrolled in 2010, the primary outcome was changed to sudden death with a pre-specified secondary outcome of total mortality, Olgin said.

He and his team are working on a number of additional analyses from this study. They also plan on transitioning patients into a registry for longer-term follow up.

Tagged with:

About author

Related Articles